Subventions financées

Amyotrophic Lateral Sclerosis (ALS) is a fatal disease that damages nerve cells controlling movement, and many patients also experience major changes in how their bodies use energy.

Impairments in social cognition (SC), such as difficulties in understanding emotions, social cues, and maintaining meaningful interactions, are key contributors to the loss of social inclusion and quality of life in individuals with neurodegenerative diseases (ND).

Amirhossein Jahani, a Postdoctoral Fellow at the University of Montreal, uses intracranial EEG to investigate how network interactions during the preictal phase (i.e., period preceding a seizure) may contribute to seizure initiation and propagation.

Contribution of stress-associated neurovascular alterations in Parkinson’s disease and high rates of depression

Jenna Hanrahan, a Doctoral Student at Memorial University of Newfoundland, aims to characterize the brain of a humanized mouse model of Huntington’s disease.

Investigating the role of EPG5 in Parkinson’s Disease pathogenesis

Using the mirror image of body’s main sugar glucose (so-called L-glucose), we plan to hijack the sugar addiction of glioblastoma (GBM) as a therapeutic target.

Amyotrophic Lateral Sclerosis (ALS) is a fatal disease that progressively destroys motor neurons, leading to paralysis and death, with no current cure.

Jenna Hanrahan, a Doctoral Student at Memorial University of Newfoundland, aims to characterize the brain of a humanized mouse model of Huntington’s disease.

The Role of Brain Endocannabinoid Metabolism in Social Anxiety Disorder and Social Stress